Lori D. Lawley
Chief Financial Officer · LUMOS PHARMA, INC.
Individual
- 2024
- Dec 13, 2024
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Lori D. Lawley's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $173.67M in KYMR purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M in KYMR purchases and sales in the last 12 months
- Keith S. Manchester - $154.47M in ROIV purchases and sales in the last 12 months
- QVT Financial LP - $147.38M in ROIV purchases and sales in the last 12 months
- Daniel Allen Gold - $147.38M in ROIV purchases and sales in the last 12 months
- ULSE Inc. - $146.25M in ULS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Lori D. Lawley?
Lori D. Lawley is a corporate insider, tracked as Chief Financial Officer of LUMOS PHARMA, INC. (LUMO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lori D. Lawley last file a Form 4?
The only primary Form 4 on record is dated 13 December 2024.
